Life Insurance After
a Heart Attack

Yes — but timing and severity matter significantly. Many heart attack survivors can eventually qualify for traditional term or whole life insurance, particularly if the heart attack was mild, was treated successfully, cardiac function (ejection fraction) is preserved, and enough time has passed since the event. The standard waiting period before most carriers will consider traditional coverage is 6 months to 2 years minimum. During that waiting period — and for more severe cases — simplified issue or guaranteed issue whole life provides coverage while you wait or as a permanent alternative.

Most traditional carriers require a minimum waiting period of 6 months to 2 years after a myocardial infarction (MI) before they'll consider an application. The specific timeline depends on the severity of the event and what treatment was required: uncomplicated STEMI or NSTEMI with stent placement, good EF, fully recovered: some carriers will consider at 6–12 months. Major event requiring bypass surgery or with EF below 50%: 1–2 years minimum, often longer. Multiple heart attacks: 2+ years from the most recent event. During the waiting period, simplified issue or guaranteed issue whole life is typically the best available option.

Ejection fraction (EF) is a measurement of how well your heart is pumping — specifically, the percentage of blood the left ventricle pumps out with each beat. Normal EF is 55–70%. EF below 50% indicates reduced cardiac function. Life insurance underwriters use ejection fraction as one of the primary indicators of how well you've recovered from a cardiac event. EF above 50% (preserved): significantly better underwriting outcome. EF 40–50% (mildly reduced): table-rated to possible decline depending on other factors. EF below 40% (reduced): most traditional carriers will decline; simplified or guaranteed issue is the path.

Yes. STEMI (ST-elevation MI) is a more severe, complete coronary artery blockage — typically treated with emergency PCI (stent) or thrombolysis. NSTEMI (non-ST-elevation MI) is a partial blockage, often less severe. Underwriters view the event's severity, treatment required, and recovery together. A STEMI fully revascularized with a drug-eluting stent, with preserved EF and no complications, is underwritten more favorably than an NSTEMI with complications, reduced EF, or additional stents. The key question for underwriters isn't just what type — it's how well did you recover and are you at risk of another event?

Familial hypercholesterolemia (FH) is a genetic disorder affecting 1 in 250 people that causes severely elevated LDL cholesterol from birth. Without treatment, FH dramatically increases the risk of early heart attack — sometimes in people's 30s or 40s. Life insurance underwriters are increasingly aware of FH. If you have a confirmed FH diagnosis with a history of cardiac events, underwriting will reflect both the FH and the cardiac history. If you have FH but no cardiac events (and are well-treated with statins, evolocumab, or similar), some carriers will offer coverage — though at higher premiums. GINA does not protect against genetic discrimination in life insurance, but FH is often diagnosed clinically (via lipid levels) rather than genetically.

Post-MI medications are viewed positively — they indicate you're following a cardiac treatment protocol. Standard post-MI medications underwriters expect to see: aspirin or antiplatelet therapy (Plavix/clopidogrel), beta-blockers (metoprolol, carvedilol), ACE inhibitors or ARBs (lisinopril, losartan), and statins (atorvastatin, rosuvastatin). Being on these medications is a positive underwriting signal — it means your cardiologist is managing you appropriately. Not being on them without explanation may raise questions. What matters most: are your cardiac risk factors controlled (cholesterol, blood pressure, blood sugar)?

Multiple myocardial infarctions significantly increase underwriting difficulty. Each event must be disclosed, and underwriters evaluate the pattern — are events getting closer together? Is the underlying disease progressing? For applicants with multiple MIs, traditional term life is often not available until several years after the most recent event and only with well-preserved cardiac function. Simplified issue whole life (health questions, no exam) may be available depending on how the questions are structured for your most recent event. Guaranteed issue whole life (no questions, everyone accepted) is available regardless of cardiac history.

A heart attack (MI) causes actual damage to heart muscle — the severity depends on how much muscle was affected. Angina is chest pain caused by reduced blood flow, without necessarily causing permanent muscle damage. Stable angina (predictable chest pain on exertion, controlled with medication) is viewed differently from unstable angina (unpredictable, occurring at rest — a warning sign of impending MI). For underwriting: stable angina well-controlled on medication = standard to mild table rating in many cases. Unstable angina or recent angina progression = more cautious underwriting, similar to recent cardiac event. Post-MI with no ongoing angina = underwritten on the MI history.